Skip to main content

Dr Guy Faust

Consultant Medical Oncologist

B. Med. Sci. BM BS. MRCP. Certificate of Completion of Training – Medical Oncology

Practises at: Three Shires Hospital

Dr-Guy- Faust -Oncologist

Personal Profile

Dr Faust graduated from Nottingham University Medical School in 1997 having completed a B.Med.Sci. degree in immunology. His initial training was in general medical specialities before commencing specialisation in oncology in 2000, gaining his MRCP qualification in 2001.

Dr Faust undertook clinical research investigating resveratrol, a red wine derivative, as an Oncology Clinical Fellow at the University of Leicester. After completing his research he began his Specialist Registrar training in oncology in 2005 at the University Hospitals of Leicester, gaining his Specialist Training Certificate in 2010. He took up his first consultant post in January of that year.

As a consultant in medical oncology he is currently the Clinical Lead in chemotherapy at Northampton General Hospital. He participates in multidisciplinary meetings in gastrointestinal, skin and urology cancers locally and supra-regional meetings in germ cell, urology and skin cancers. Dr Faust is currently an investigator in a number of national and international clinical trials. He is able to offer a treatment portfolio that is not routinely available within the NHS including such treatments as Erbitux, Avastin, Yervoy, Jevtana and Zygita. Dr Faust is also happy to offer a second opinion or further explanation in relation to your cancer.

Clinical Interests

Oncologist with a specialist interest in the following cancer types:

  • Lower gastrointestinal cancer – including colonic, rectal and gastrointestinal stromal tumours
  • Malignant melanoma
  • Urological cancers – including kidney, bladder and prostate cancers
  • Germ cell cancers – testicular and non testicular
  • Cancers of unknown primary

Professional Memberships

  • General Medical Council (GMC)
  • Member of the Royal College of Physicians (RCP)
  • European Society of Medical Oncology (ESMO)
i